Our study revealed the intracellular function of APOL1 as a tumor suppressor in renal cancer cell EMT and metastasis through FAK/Akt/GSK3β and NFκB, which may be potentially targeted to control ccRCC metastasis (Figure 5). The gene discussed is NFKB1; the disease is nonpapillary renal cell carcinoma.